Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.

ABSTRACT:

Background

Pneumocystis pneumonia (PCP) is a disease affecting immunocompromised patients. PCP among these patients is associated with significant morbidity and mortality.

Objectives

To assess the effectiveness of PCP prophylaxis among non-HIV immunocompromised patients; and to define the type of immunocompromised patient for whom evidence suggests a benefit for PCP prophylaxis.

Search methods

Electronic searches of the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2014, Issue 1), MEDLINE and EMBASE (to March 2014), LILACS (to March 2014), relevant conference proceedings; and references of identified trials.

Selection criteria

Randomised controlled trials (RCTs) or quasi-RCTs comparing prophylaxis with an antibiotic effective ag

SUBMITTER: Stern A 

PROVIDER: S-EPMC6457644 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature